Speakers

Michael Thomas

Inova Personalized Healthcare Accelerator

Michael Thomas is director of the Inova Personalized Healthcare Accelerator. Prior to Inova, Thomas was CEO of Appian Partners, a Maryland-based life sciences consulting practice. His med-tech experience has spanned several early-stage, growth stage and turn-around ventures as CEO of Appian Partners, ReGear Life Sciences, NuSomnea, Tanzen Medical, Appian Medical, iSonea and Sleep Solutions. Thomas was founder and CEO of Appian Medical, a digital health firm that developed an algorithm to diagnose Obstructive Sleep Apnea. Thomas spent three years as CEO of iSonea, a publicly-traded global, asthma digital healthcare company. Earlier in his career, Thomas was CEO of Sleep Solutions, a VC-­backed medical device manufacturer. Prior to Sleep Solutions, Thomas was EVP of Sales and Marketing for National Sleep Technologies (NST), where he led acquisitions of more than 80 sleep labs, making NST the largest sleep testing company in the U.S. Thomas graduated from Cornell University.

Dr. Mike Buschmann

George Mason University

Dr. Michael Buschmann is Chair of the Department of Bioengineering in  the Volgenau School of Engineering at George Mason University . Dr. Buschmann received a Ph.D. in Medical Engineering and Medical Physics from MIT and Harvard University in 1992, and postdoctoral training from the University of Bern, Switzerland from 1992-1994. From 1994 to July 2017, Dr. Buschmann was Professor of Biomedical Engineering and Chemical Engineering at Polytechnique de Montréal. Dr. Buschmann became Chair of the Department of Bioengineering in the Volgenau School of Engineering at George Mason University in August 2017. Dr. Buschmann has founded or served as principal inventor at Biosyntech Inc (cartilage repair) sold to Smith and Nephew; Biomomentum Inc. (instrumentation); ANRis Pharma (RNA delivery); and Ortho Regenerative Technologies Inc (tendon/meniscus repair).

Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S.

BioFactura Inc.

Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S., is an associate clinical professor of surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Dr. Hausfeld is widely-published, a pioneer of innovative laser surgery techniques and has appeared on numerous programs as a medical expert. Dr. Hausfeld is developing assisted living facilities specializing in Alzheimer’s and dementia care and serves as a consultant to several health tech startups. He also serves on the Investment Advisory Board of the Center for Innovation Technology’s Life Science Gap Fund. Dr. Hausfeld is Chairman and founder of the Society of Physician Entrepreneurs. Dr. Hausfeld recently orchestrated the oversubscribed Series A Financing of BioFactura. He serves as Chairman of the Board of BioFactura, as well as chief medical officer.

Dr. Crystal R. Icenhour

Aperiomics

Dr. Crystal R. Icenhour is CEO and co-founder of Aperiomics. Aperiomics’ focus is to harness the power of next-generation sequencing to improve world health. Dr. Icenhour received her PhD in pathobiology and molecular medicine from the University of Cincinnati Medical School of Graduate Studies in 2002.  She conducted postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College of Medicine from 2002-2005 and in the Department of Infectious Diseases at Duke University Medical Center from 2005-2006. Dr. Icenhour has been involved in national postdoctoral associations including the Mayo Research Fellows Association Executive Committee, the Duke University Postdoctoral Association and the National Postdoctoral Association. Dr. Icenhour has been recognized by Kauffman Foundation and Center for Innovative Technology as an outstanding entrepreneur. Dr. Icenhour was president and chief science officer for Phthisis Diagnostics from 2007-2013. In 2014, Dr. Icenhour was recruited as CEO of Aperiomics.

Kristi Jones

NexImmune

Kristi Jones brings more than 25 years of business leadership experience in the biotech and pharmaceutical industries. Jones currently serves as chief operating officer at NexImmune. For five years prior to NexImmune, Jones was with Astra Zeneca and its subsidiary MedImmune. From 2013-2015, Jones was vice president of portfolio strategy and management at Astra Zeneca, where she played an instrumental role in building a scientifically innovative, diverse portfolio, creating new value for the company. Prior to that she served as vice president of global strategic marketing to shape product plans and prepare MedImmune for multiple launches. Previously, Jones held leadership roles with increasing responsibility at Genentech, including head of Immunology and Ophthalmology in Global Portfolio and Product Strategy, Endocrine and Pulmonary Franchise, and Immunology Business Unit Operations and Pipeline Planning.  Jones also serves on the Life Science Panel for Springboard Enterprises focused on startup companies led by women.

Kim Radefeld

CGI

Kim Radefeld is a director in CGI Group’s health and life sciences practice and an expert in customer experience development. She is a seasoned executive with extensive life sciences and healthcare experience as well as significant service-side leadership and consultancy experience. She is adept in creating and implementing innovative business and marketing initiatives with an emphasis on omni-channel marketing, patient engagement and adherence, pharmacovigilance, IT systems, data analytics and multi-source integration

Fritz Haimberger

Appian

Fritz Haimberger is a healthcare consulting, sales, and management executive with more than eighteen years of HIT, clinical operations, and revenue cycle experience. With a strong background in healthcare administration and operations, business development and IT systems design, Haimberger has extensive experience focusing on provider solutions both in the U.S. and internationally, including Canada, Ireland, and the UK. Having been with Appian for three years and leading the company’s healthcare provider industry vertical, Haimberger holds a B.E. in Biomedical Engineering from Vanderbilt University and resides with his family in Nashville, Tenn.

Mary Butler-Everson

PNC

Mary Butler-Everson is senior vice president of Healthcare Product Innovation at PNC Financial Services. Prior to joining PNC Healthcare in 2011, Butler-Everson served as senior vice president and chief marketing officer for a national life and health insurance company. In her role she was responsible for corporate strategy, product development, brand management and marketing communications, strategic partnerships, project management, and process improvement. Previously, Butler-Everson spent nearly 20 years in healthcare working in and with integrated health systems, academic medical centers and physician practice plans directing strategy, business development, mergers/acquisitions, clinical operations as well as physician practice management. Butler-Everson has a Master of Science in Health Systems and Policy from Carnegie Mellon University and a Bachelor of Science in Health Planning and Administration from Pennsylvania State University.

Jeremy Walsh

Booz Allen Hamilton

Jeremy Walsh, a leader for Booz Allen Analytics, has over 20 years’ experience in software engineering, data science, big data architecture, cloud computing and project and program management for complex distributed computing solutions. Walsh currently supports the FDA, CDC, and NIH. Walsh is the currently the program manager for the FDA RAPID program, an innovative mobile and cloud-based data analytics solution that incorporates the latest in blockchain technology. Previously, Walsh designed and led the Booz Allen Sailfish product and has supported various U.S. Government agencies and commercial organizations in building complex distributed systems. Walsh has experience as an executive, entrepreneur and inventor and holds a B.S in computer science from the University of Maryland and multiple patents.

Todd Stottlemyer

Inova Center for Personalized Health

Todd Stottlemyer joined Inova in July 2015 as CEO of the Inova Center for Personalized Health (ICPH). Stottlemyer is responsible for developing and growing all activities on the 117-acre ICPH campus, which includes the Inova Schar Cancer Institute and the Inova Translational Medicine Institute (ITMI). He also provides executive leadership for Inova’s overall research efforts, the Inova Strategic Investment Initiative, the Inova Personalized Health Accelerator, and government relations.

Stottlemyer previously served at Inova from 2009-10 as executive vice president responsible for information technology, biomedical engineering, innovation, international business, compliance, risk, legal, communications, government relations, community affairs and philanthropy.

Prior to returning to Inova, Stottlemyer was CEO of Acentia, LCC, a private equity backed provider of software, information technology and management solutions. Before Acentia, Stottlemyer led as CEO, CFO, and as a member of the executive management teams of three technology companies, two of which were private equity backed and two were publicly traded on the NASDAQ. Stottlemyer also served as CEO of the National Federation of Independent Business, the nation’s largest business association, and as president of McGuireWoods Consulting.

Stottlemyer has been recognized by Washington Smart CEO magazine as one of their 20 “Most Admired CEOs” in the Washington, D.C. region; by the Washington Business Journal as one of the 50 “Most Admired CEOs” in the Washington, D.C. region and as one of the Washington, D.C. region’s 100 most influential leaders; and by Virginia Business as one of 31 people “…making their mark on the Commonwealth’s economy.”

Stottlemyer has served on or serves on the boards of 10 technology companies, two publicly-traded commercial banks, and a technology-focused venture capital firm. Additionally, he has served on the boards of numerous charitable and civic organizations, including serving as Chairman of the Fairfax County Chamber of Commerce board of directors and as a Commissioner on the Fairfax County Economic Development Authority. Stottlemyer is Chair Emeritus of the NVTC Board of Directors. Stottlemyer serves as Rector (chair of the Board of Visitors) of The College of William & Mary. Previously, he served as a member of the University of Mary Washington’s Board of Visitors. Stottlemyer also has been a guest lecturer at the Mason School of Business (The College of William & Mary) and the Wharton School of Business (University of Pennsylvania).

Stottlemyer received his Bachelor of Arts (Phi Beta Kappa) from The College of William & Mary. He received a JD (cum laude) from Georgetown University Law Center and is a member of the Virginia State Bar.

Mudar Yaghi

AppTek

Mudar Yaghi has over 25 years of experience in the field of software development, systems implementation and corporate management. In 1990, Yaghi co-founded AppTek, a pioneer in automatic speech recognition, machine translation, machine learning, artificial intelligence and natural language processing. As CEO of AppTek, Yaghi supervised the design and development of speech and translation systems for large scale deployments. In 1998, Yaghi managed the M&A of AppTek to Lernout & Hauspie, and then the buyback of AppTek through an MBO in 2001. In 2010, he managed the M&A of AppTek to SAIC, and then the buyback of AppTek in 2013. In 2014, he managed the M&A of AppTek’s machine translation technology to eBay, where he joined eBay’s machine learning and AI team to transition the technology, scientists and engineers. Yaghi currently serves as the chairman and CEO of AppTek, and sits on the board of Net2Voice, Ignite-TEK, Pixelligent and TCOM. Yaghi holds a M.S. degree in information systems from George Washington University.

Dr. Jim Kyung-Soo Liew

SoKat.co

Dr. Jim Kyung-Soo Liew is assistant professor of finance at Johns Hopkins University’s Carey Business School. He has published pioneering research in the intersection of social media big data, crypto-currencies and financial markets. Dr. Liew teaches “Big Data Machine Learning,” “Blockchain,” “Advanced Hedge Fund Strategies,” and “Leading Entrepreneurship and Innovation” at the Johns Hopkins Carey Business School. Additionally, he serves as chairman of the Johns Hopkins Innovation Factory. Dr. Liew also owns and operates SoKat Consulting, LLC. SoKat creates world-class machine learning, AI and blockchain products and services primarily servicing institutional investors, government agencies, academic institutions and select startups. Dr. Liew holds a B.A. in mathematics from the University of Chicago and a doctorate in finance from Columbia University. Dr. Liew is a Newsweek AI and Data Science Advisory Board member and serves on NaisA Board’s Executive Committee.

Shirley McElhatton

MedStar Georgetown University Hospital

Shirley McElhatton serves as the director of Patient Service Excellence at MedStar Georgetown University Hospital, a role which oversees patient advocacy, patient experience, volunteer coordination and guest services. As a registered nurse with 30 years of experience, McElhatton worked in many patient care roles in Dublin, London and Stamford, Conn., before coming to the Greater Washington region. These roles have included clinical management, nurse education, nurse recruitment and patient advocacy. McElhatton is responsible for the patient experience survey results analysis and dissemination as well as the management of the complaint and grievance data. She is also responsible for best practice benchmarking and metrics associated with patient relations mission to assist the Hospital in continually improving patient experience and serves as an integral member of the Patient Experience initiative. McElhatton works closely with MedStar Corporate’s Patient Experience team as well as MedStar’s survey process vendor, National Research Corporation, ensuring survey integrity and alignment with MedStar’s patient experience measurement process and goals.

Jon Booth

Centers for Medicare & Medicaid Services (CMS)

Jon Booth is the director of the Web and New Media Group in the CMS Office of Communications (OC). In this position, Booth oversees the CMS public websites program, which includes Healthcare.gov, Medicare.gov, MyMedicare.gov CMS.gov, Medicaid.gov, InsureKidsNow.gov and other websites. Booth is leading a team consisting of internal CMS staff and contract developers focused on an effort to modernize CMS’ public websites, including cloud migration, mobile optimization, development of public APIs, and improvements to the online services CMS offers to citizens under all of the programs the Agency oversees. Prior to this position, Booth was the deputy director of the Creative Services Group. In this position he led the launch of the Agency’s social media channels as well as the Medicare & You Web project. Booth has worked throughout CMS through his career and has supported the launch of the Agency’s websites, IT governance and numerous communication initiatives. Booth has been at CMS for over 20 years.

Jon Hoehne

Dovel Technologies

Jon Hoehne is responsible for driving business operations improvements in software development and IT services at Dovel Technologies. Hoehne has led the planning and managing the re-appraisal of Dovel software development projects at CMMI Maturity Level 3 as well as the research, design, development and deployment of Liquid Frame™, Dovel’s standard approach to software development. He also plays a lead role in the Dovel Emerging Markets Team, focused on incorporating the latest technology in IT solutions. Hoehne brings over 15 years of dynamic and innovative process improvement experience to the Dovel team. Hoehne previously held quality analyst roles with Northrop Grumman and General Dynamics. Hoehne is a Lean Six Sigma Black Belt and Certified Manager of Quality/Organizational Excellence (CMQ/OE) and holds a Bachelor of Science in Computer Science from Virginia Tech and a Master of Science, Management of Information Technology from University of Virginia.

Jose Arrieta

U.S. Dept of Health & Human Services

Jose Arrieta serves as associate deputy assistant secretary for Acquisition, assistant secretary for Financial Resources at the U.S. Department of Health and Human Services, a role he has held since January 2018. Prior to that he served as director of the Office of IT at GSA where he led Schedule 70, the largest IT contract in the world, valued at approximately $15 billion per year. Arrieta provided technology acquisition leadership to a workforce distributed across five states and to customers at the federal, state and local levels of government. Before GSA, Arrieta served at the Treasury Department as director of the Office of Small Disadvantage Business Utilization and as the Homeland Security Department’s industry liaison and ombudsman. From 2004-2010, Arrieta was a procurement analyst and contracting officer at GSA. Arrieta received a B.S. in business administration from Susquehanna University and an MBA from American University. Arrieta is also an adjunct professor at University of Virginia.

Raymond Sczudlo

b.well

Raymond S. Sczudlo serves as general counsel at b.well Connected Health, Inc., an early stage company that unifies all aspects of your health in a single place, for life, and puts you in control. He holds a J.D. from the Georgetown University Law Center and a bachelor’s in chemical engineering from the University of Detroit. From 2001 to 2015, Sczudlo served as executive vice president and chief legal officer of Children’s National Medical Center. At Children’s National, he led the legal affairs of the organization, with responsibility for compliance, internal audit, joint ventures, operating agreements, insurance, corporate governance and safety and risk management, reporting directly to the CEO. Prior to Children’s National, Sczudlo served in a business development and legal counsel role for a variety of startup companies specializing in telemedicine, Internet video and digital security. Prior to that, Sczudlo was a partner at Weil, Gotshal & Manges LLP.

Dr. Henry “Skip” Francis

Food & Drug Administration

Since 2013, Dr. Francis has served as director of the Data mining and Informatics Evaluation and Research Group in the Office of Translational Sciences, Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). He directs a trans-disciplinary group of scientists to test, create and operate a data analysis program to evaluate data to make regulatory decisions for drug approval and safety. From 2007 to 2013, Dr. Francis was deputy director of the Office of Surveillance and Epidemiology (OSE) in the CDER at the FDA. Dr. Francis leads scientists in the study of adverse medical events occurring after the release of new drugs into the American health market. As a clinician, Dr. Francis was an assistant professor of medicine at the Johns Hopkins University School of Medicine’s Division of Infectious diseases. He completed his Internal Medicine residency training at the Long Beach Veterans Administration Hospital and infectious diseases specialty training at the Johns Hopkins Hospital Division of Infectious Diseases.

Jon White

U. S. Department of Health and Human Services

Dr. Jon White serves as deputy national coordinator for health information technology. Dr. White has dedicated his career to improving health and healthcare quality through the use of electronic health information. At ONC, Dr. White provides executive direction for all ONC programs and policies, and advances key priorities. He has led mission-critical activities, including the publication of high-priority, nationally impactful regulations, the publication of the Shared Nationwide Interoperability Roadmap, and ONC’s efforts in the precision medicine initiative. Before ONC, Dr. White was director of the Division of Health IT at the Agency for Healthcare Research and Quality. Dr. White has deep experience working with federal partners (Centers for Medicare and Medicaid Services and the Department of Veterans Affairs), as well as key healthcare patient, policy and health IT stakeholder groups to implement major healthcare initiatives. Dr. White trained in family medicine at the University of Virginia and Lancaster General Hospital.

Charles Worthington

U.S. Department of Veterans Affairs

Charles Worthington is a software developer and product designer who has been helping the government adopt modern digital service delivery best practices since 2013. He is currently serving as the Chief Technology Officer at the U.S. Department of Veterans Affairs, where he is working to improve the experience Veterans have when interacting with VA online. Since joining VA in May 2017, Worthington has guided VA’s Digital Modernization initiative. His efforts include the development of the agency’s Digital Strategy, supporting VA’s adoption of commercial cloud infrastructure, and supporting the development Vets.gov – VA’s modern customer-facing platform.

Prior to joining VA in May 2017, Worthington helped create the U.S. Digital Service, a team of world-class developers, designers and product experts serving tours of duty in the Federal government to use design and technology to deliver better services to the American people. He is the co-author of the Digital Services Playbook (https://playbook.cio.gov) and executed digital service engagements at USCIS, SBA, DOT, and Interior. Before his federal service, Worthington built products for private sector clients and was a strategy consultant in the tech & telecom sectors. He holds a B.A. from Harvard University.

Jerry Berger

Samsung Electronics America, Inc.

Jerry Berger has over 20 years of experience in the healthcare IT space. He is currently the senior manager for healthcare solutions at Samsung Electronics America, where he markets mobility and wearable solutions to hospitals, long-term care and consumer health organizations. Prior to his current role, Jerry worked for Siemens Healthcare and marketed healthcare analytics and value-added services to acute care hospitals.

Pete Jobse

Inova Personalized Health Accelerator

Pete Jobse is a managing director of Inova Strategic Investments and the Inova Personalized Health Accelerator. He is responsible for leading Inova’s innovation investing and development for companies that are transforming Inova and global health services. Jobse has been a corporate officer for publicly-traded high technology companies, founder of a venture funded startup company, and CEO of a nonprofit innovation investment and consulting company. Prior to Inova Strategic Investments, Jobse served as the CEO of the Center for Innovative Technology (CIT) where he created CIT’s seed stage venture funds, a portfolio of three funds containing over 135 companies, CIT’s research commercialization fund, a portfolio of 90 research investments, and MACH37, the first cybersecurity accelerator. Prior to CIT, he was senior vice president of ArcSight during company formation and product development. In 2008, ArcSight completed a successful IPO and was sold to Hewlett Packard for $1.5 billion. Prior to ArcSight, Jobse was COO of Condor Technology Solutions (CNDR), a web and e-business solutions provider acquired by CACI. Jobse began his career at Electronic Data Systems, where he worked for 20 years. Jobse has 36 years of experience in the technology industry with experience in all aspects of business operations, including market assessment, strategic planning, product development, sales, merger and acquisition, and operational delivery. Jobse is a graduate of the Indiana University of Pennsylvania.